25 XP   0   0   10

Entia Biosciences Inc
Buy, Hold or Sell?

Let's analyse Entia Biosciences Inc together

PenkeI guess you are interested in Entia Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Entia Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Entia Biosciences Inc

I send you an email if I find something interesting about Entia Biosciences Inc.

Quick analysis of Entia Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Entia Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.06
Expected worth in 1 year
$-0.20
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-0.14
Return On Investment
-139,672.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%

1. Valuation of Entia Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.25 - $-0.11

Total Value Per Share

$-0.31 - $-0.17

2. Growth of Entia Biosciences Inc (5 min.)




Is Entia Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.9m-$791.1k-$1.1m-59.8%

How much money is Entia Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$2.4m$936.6k63.6%
Net Profit Margin-554.7%-694.5%--

How much money comes from the company's main activities?

3. Financial Health of Entia Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Entia Biosciences Inc? (5 min.)

Welcome investor! Entia Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Entia Biosciences Inc.

What can you expect buying and holding a share of Entia Biosciences Inc?

First you should know what it really means to hold a share of Entia Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Entia Biosciences Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Entia Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Entia Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.06. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Entia Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-41,466.0%-0.04-41,466.0%-0.07-67,141.7%-0.06-63,408.4%-0.05-47,806.7%
Usd Book Value Change Per Share-0.03-34,918.1%-0.03-34,918.1%-0.02-20,042.6%-0.01-10,141.2%-0.01-6,491.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-34,918.1%-0.03-34,918.1%-0.02-20,042.6%-0.01-10,141.2%-0.01-6,491.4%
Usd Price Per Share0.06-0.06-0.09-0.29-0.19-
Price to Earnings Ratio-1.35--1.35--1.34--4.61--3.74-
Price-to-Total Gains Ratio-1.60--1.60--4.49--21.63--17.85-
Price to Book Ratio-0.96--0.96--3.83--22.25--12.65-
Price-to-Total Gains Ratio-1.60--1.60--4.49--21.63--17.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.03-0.01
Gains per Quarter (10000000 shares)-349,180.50-101,411.96
Gains per Year (10000000 shares)-1,396,722.01-405,647.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1396722-13967320-405648-405658
20-2793444-27934540-811296-811306
30-4190166-41901760-1216944-1216954
40-5586888-55868980-1622591-1622602
50-6983610-69836200-2028239-2028250
60-8380332-83803420-2433887-2433898
70-9777054-97770640-2839535-2839546
80-11173776-111737860-3245183-3245194
90-12570498-125705080-3650831-3650842
100-13967220-139672300-4056479-4056490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.06.00.033.3%3.06.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.06.00.033.3%3.06.00.033.3%

Fundamentals of Entia Biosciences Inc

About Entia Biosciences Inc

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

Fundamental data was last updated by Penke on 2024-05-16 08:34:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Entia Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Entia Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -554.7% means that $-5.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Entia Biosciences Inc:

  • The MRQ is -554.7%. The company is making a huge loss. -2
  • The TTM is -554.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-554.7%TTM-554.7%0.0%
TTM-554.7%YOY-694.5%+139.8%
TTM-554.7%5Y-619.4%+64.6%
5Y-619.4%10Y-542.7%-76.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-554.7%-177.0%-377.7%
TTM-554.7%-223.7%-331.0%
YOY-694.5%-256.7%-437.8%
5Y-619.4%-431.4%-188.0%
10Y-542.7%-551.3%+8.6%
1.1.2. Return on Assets

Shows how efficient Entia Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • -335.4% Return on Assets means that Entia Biosciences Inc generated $-3.35 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Entia Biosciences Inc:

  • The MRQ is -335.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -335.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-335.4%TTM-335.4%0.0%
TTM-335.4%YOY-537.1%+201.7%
TTM-335.4%5Y-404.0%+68.6%
5Y-404.0%10Y-321.7%-82.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-335.4%-11.9%-323.5%
TTM-335.4%-11.7%-323.7%
YOY-537.1%-10.8%-526.3%
5Y-404.0%-13.0%-391.0%
10Y-321.7%-14.2%-307.5%
1.1.3. Return on Equity

Shows how efficient Entia Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Entia Biosciences Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Entia Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-24.2%+24.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.1%+15.1%
TTM--14.7%+14.7%
YOY--13.3%+13.3%
5Y--17.6%+17.6%
10Y-24.2%-19.1%-5.1%

1.2. Operating Efficiency of Entia Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Entia Biosciences Inc is operating .

  • Measures how much profit Entia Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -439.7% means the company generated $-4.40  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Entia Biosciences Inc:

  • The MRQ is -439.7%. The company is operating very inefficient. -2
  • The TTM is -439.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-439.7%TTM-439.7%0.0%
TTM-439.7%YOY-552.3%+112.5%
TTM-439.7%5Y-481.3%+41.6%
5Y-481.3%10Y-448.5%-32.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-439.7%-348.2%-91.5%
TTM-439.7%-232.7%-207.0%
YOY-552.3%-266.9%-285.4%
5Y-481.3%-412.2%-69.1%
10Y-448.5%-516.7%+68.2%
1.2.2. Operating Ratio

Measures how efficient Entia Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.40 means that the operating costs are $5.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Entia Biosciences Inc:

  • The MRQ is 5.397. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.397. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.397TTM5.3970.000
TTM5.397YOY6.523-1.125
TTM5.3975Y5.813-0.416
5Y5.81310Y5.382+0.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3973.097+2.300
TTM5.3973.332+2.065
YOY6.5233.564+2.959
5Y5.8135.224+0.589
10Y5.3826.637-1.255

1.3. Liquidity of Entia Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Entia Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.11 means the company has $0.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Entia Biosciences Inc:

  • The MRQ is 0.111. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.111. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.111TTM0.1110.000
TTM0.111YOY0.104+0.008
TTM0.1115Y0.214-0.102
5Y0.21410Y1.530-1.317
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1113.798-3.687
TTM0.1114.146-4.035
YOY0.1045.212-5.108
5Y0.2146.093-5.879
10Y1.5306.441-4.911
1.3.2. Quick Ratio

Measures if Entia Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.04 means the company can pay off $0.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Entia Biosciences Inc:

  • The MRQ is 0.040. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.040. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.040TTM0.0400.000
TTM0.040YOY0.025+0.015
TTM0.0405Y0.103-0.064
5Y0.10310Y0.646-0.542
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0403.165-3.125
TTM0.0403.776-3.736
YOY0.0255.140-5.115
5Y0.1035.839-5.736
10Y0.6466.367-5.721

1.4. Solvency of Entia Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Entia Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Entia Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 5.48 means that Entia Biosciences Inc assets are financed with 547.8% credit (debt) and the remaining percentage (100% - 547.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Entia Biosciences Inc:

  • The MRQ is 5.478. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.478. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ5.478TTM5.4780.000
TTM5.478YOY2.764+2.715
TTM5.4785Y2.856+2.622
5Y2.85610Y2.000+0.856
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4780.340+5.138
TTM5.4780.341+5.137
YOY2.7640.279+2.485
5Y2.8560.366+2.490
10Y2.0000.380+1.620
1.4.2. Debt to Equity Ratio

Measures if Entia Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Entia Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.057-0.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.415-0.415
YOY-0.356-0.356
5Y-0.443-0.443
10Y0.0570.469-0.412

2. Market Valuation of Entia Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Entia Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Entia Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.35 means the investor is paying $-1.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Entia Biosciences Inc:

  • The EOD is -0.002. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.351. Based on the earnings, the company is expensive. -2
  • The TTM is -1.351. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-1.351+1.348
MRQ-1.351TTM-1.3510.000
TTM-1.351YOY-1.340-0.010
TTM-1.3515Y-4.609+3.258
5Y-4.60910Y-3.742-0.866
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.002-2.289+2.287
MRQ-1.351-2.558+1.207
TTM-1.351-2.723+1.372
YOY-1.340-3.900+2.560
5Y-4.609-6.368+1.759
10Y-3.742-6.544+2.802
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Entia Biosciences Inc:

  • The EOD is -0.005. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.610. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.610. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.005MRQ-2.610+2.605
MRQ-2.610TTM-2.6100.000
TTM-2.610YOY-5.431+2.821
TTM-2.6105Y-17.275+14.665
5Y-17.27510Y-11.696-5.580
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.005-3.247+3.242
MRQ-2.610-3.308+0.698
TTM-2.610-3.522+0.912
YOY-5.431-5.154-0.277
5Y-17.275-8.005-9.270
10Y-11.696-8.608-3.088
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Entia Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.96 means the investor is paying $-0.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Entia Biosciences Inc:

  • The EOD is -0.002. Based on the equity, the company is expensive. -2
  • The MRQ is -0.959. Based on the equity, the company is expensive. -2
  • The TTM is -0.959. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-0.959+0.957
MRQ-0.959TTM-0.9590.000
TTM-0.959YOY-3.829+2.870
TTM-0.9595Y-22.246+21.288
5Y-22.24610Y-12.645-9.601
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0021.996-1.998
MRQ-0.9592.027-2.986
TTM-0.9592.073-3.032
YOY-3.8292.696-6.525
5Y-22.2463.727-25.973
10Y-12.6454.109-16.754
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Entia Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.035-0.0350%-0.020-43%-0.010-71%-0.006-81%
Book Value Per Share---0.058-0.0580%-0.024-60%-0.027-55%-0.014-76%
Current Ratio--0.1110.1110%0.104+8%0.214-48%1.530-93%
Debt To Asset Ratio--5.4785.4780%2.764+98%2.856+92%2.000+174%
Debt To Equity Ratio----0%-0%-0%0.057-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.041-0.0410%-0.067+62%-0.063+53%-0.048+15%
Free Cash Flow Per Share---0.021-0.0210%-0.017-23%-0.019-11%-0.017-22%
Free Cash Flow To Equity Per Share--0.0020.0020%-0.002+245%0.000+337%0.001+155%
Gross Profit Margin--1.0611.0610%1.053+1%1.048+1%1.0660%
Intrinsic Value_10Y_max---0.114--------
Intrinsic Value_10Y_min---0.249--------
Intrinsic Value_1Y_max---0.017--------
Intrinsic Value_1Y_min---0.021--------
Intrinsic Value_3Y_max---0.048--------
Intrinsic Value_3Y_min---0.068--------
Intrinsic Value_5Y_max---0.073--------
Intrinsic Value_5Y_min---0.118--------
Market Cap3366.090-55900%1885010.4001885010.4000%3029481.000-38%9768393.180-81%6511514.100-71%
Net Profit Margin---5.547-5.5470%-6.945+25%-6.194+12%-5.427-2%
Operating Margin---4.397-4.3970%-5.523+26%-4.813+9%-4.485+2%
Operating Ratio--5.3975.3970%6.523-17%5.813-7%5.382+0%
Pb Ratio-0.002+100%-0.959-0.9590%-3.829+299%-22.246+2221%-12.645+1219%
Pe Ratio-0.002+100%-1.351-1.3510%-1.340-1%-4.609+241%-3.742+177%
Price Per Share0.000-55900%0.0560.0560%0.090-38%0.290-81%0.193-71%
Price To Free Cash Flow Ratio-0.005+100%-2.610-2.6100%-5.431+108%-17.275+562%-11.696+348%
Price To Total Gains Ratio-0.003+100%-1.604-1.6040%-4.490+180%-21.632+1249%-17.846+1013%
Quick Ratio--0.0400.0400%0.025+58%0.103-61%0.646-94%
Return On Assets---3.354-3.3540%-5.371+60%-4.040+20%-3.217-4%
Return On Equity----0%-0%-0%-0.2420%
Total Gains Per Share---0.035-0.0350%-0.020-43%-0.010-71%-0.006-81%
Usd Book Value---1966561.000-1966561.0000%-791188.000-60%-894433.000-55%-470188.333-76%
Usd Book Value Change Per Share---0.035-0.0350%-0.020-43%-0.010-71%-0.006-81%
Usd Book Value Per Share---0.058-0.0580%-0.024-60%-0.027-55%-0.014-76%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.041-0.0410%-0.067+62%-0.063+53%-0.048+15%
Usd Free Cash Flow---722215.000-722215.0000%-557851.000-23%-643014.600-11%-563746.778-22%
Usd Free Cash Flow Per Share---0.021-0.0210%-0.017-23%-0.019-11%-0.017-22%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%-0.002+245%0.000+337%0.001+155%
Usd Market Cap3366.090-55900%1885010.4001885010.4000%3029481.000-38%9768393.180-81%6511514.100-71%
Usd Price Per Share0.000-55900%0.0560.0560%0.090-38%0.290-81%0.193-71%
Usd Profit---1472664.000-1472664.0000%-2409334.000+64%-2258978.200+53%-1678433.111+14%
Usd Revenue--265466.000265466.0000%346910.000-23%390547.400-32%311748.222-15%
Usd Total Gains Per Share---0.035-0.0350%-0.020-43%-0.010-71%-0.006-81%
 EOD+2 -6MRQTTM+0 -0YOY+15 -175Y+12 -2010Y+9 -24

3.2. Fundamental Score

Let's check the fundamental score of Entia Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.002
Price to Book Ratio (EOD)Between0-1-0.002
Net Profit Margin (MRQ)Greater than0-5.547
Operating Margin (MRQ)Greater than0-4.397
Quick Ratio (MRQ)Greater than10.040
Current Ratio (MRQ)Greater than10.111
Debt to Asset Ratio (MRQ)Less than15.478
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.354
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Entia Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2016-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets439
Total Liabilities2,406
Total Stockholder Equity-1,967
 As reported
Total Liabilities 2,406
Total Stockholder Equity+ -1,967
Total Assets = 439

Assets

Total Assets439
Total Current Assets234
Long-term Assets205
Total Current Assets
Cash And Cash Equivalents 76
Net Receivables 8
Inventory 70
Other Current Assets 81
Total Current Assets  (as reported)234
Total Current Assets  (calculated)234
+/-0
Long-term Assets
Property Plant Equipment 18
Intangible Assets 187
Long-term Assets  (as reported)205
Long-term Assets  (calculated)205
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,106
Long-term Liabilities300
Total Stockholder Equity-1,967
Total Current Liabilities
Short-term Debt 746
Short Long Term Debt 746
Accounts payable 653
Other Current Liabilities 707
Total Current Liabilities  (as reported)2,106
Total Current Liabilities  (calculated)2,852
+/- 746
Long-term Liabilities
Long term Debt 300
Long-term Liabilities  (as reported)300
Long-term Liabilities  (calculated)300
+/-0
Total Stockholder Equity
Common Stock28
Retained Earnings -14,473
Accumulated Other Comprehensive Income -9
Other Stockholders Equity 12,487
Total Stockholder Equity (as reported)-1,967
Total Stockholder Equity (calculated)-1,967
+/- 0
Other
Cash and Short Term Investments 76
Common Stock Shares Outstanding 28,137
Current Deferred Revenue-653
Liabilities and Stockholders Equity 439
Net Debt 970
Net Tangible Assets -2,153
Net Working Capital -1,871
Short Long Term Debt Total 1,046



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
0
499
503
443
405
463
631
871
449
439
4394498716314634054435034990
   > Total Current Assets 
0
499
437
317
258
244
225
485
128
234
2341284852252442583174374990
       Cash And Cash Equivalents 
0
273
48
65
17
13
37
99
24
76
76249937131765482730
       Net Receivables 
0
0
3
22
36
66
15
244
7
8
8724415663622300
       Other Current Assets 
0
26
11
15
32
33
34
46
57
81
8157463433321511260
   > Long-term Assets 
0
0
67
125
147
219
406
386
320
205
2053203864062191471256700
       Property Plant Equipment 
0
0
18
43
32
36
62
43
33
18
183343623632431800
       Intangible Assets 
0
0
36
81
115
183
343
343
233
187
187233343343183115813600
       Other Assets 
0
0
0
0
0
0
0
47
55
0
055470000000
> Total Liabilities 
0
58
138
748
665
1,111
1,581
987
1,240
2,406
2,4061,2409871,5811,111665748138580
   > Total Current Liabilities 
0
58
138
551
600
1,109
1,581
987
1,240
2,106
2,1061,2409871,5811,109600551138580
       Short-term Debt 
0
17
17
210
268
454
423
418
279
746
74627941842345426821017170
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
746
746000000000
       Accounts payable 
0
6
111
0
0
0
1
0
595
653
6535950100011160
       Other Current Liabilities 
0
0
10
341
332
654
1,157
569
365
707
7073655691,1576543323411000
   > Long-term Liabilities 
0
23
128
197
65
2
423
418
279
300
300279418423265197128230
> Total Stockholder Equity
0
440
365
-305
-260
-648
-950
-117
-791
-1,967
-1,967-791-117-950-648-260-3053654400
   Retained Earnings -14,473-13,077-10,817-8,520-5,328-4,042-2,313-815-1220
   Accumulated Other Comprehensive Income 
0
1
0
0
0
0
0
0
-52
-9
-9-5200000010
   Capital Surplus 0000000000
   Treasury Stock0000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2016-12-31)

Gross Profit (+$)
totalRevenue265
Cost of Revenue-91
Gross Profit174174
 
Operating Income (+$)
Gross Profit174
Operating Expense-1,341
Operating Income-1,167-1,167
 
Operating Expense (+$)
Research Development38
Selling General Administrative1,251
Selling And Marketing Expenses90
Operating Expense1,3411,379
 
Net Interest Income (+$)
Interest Income0
Interest Expense-84
Other Finance Cost-0
Net Interest Income-84
 
Pretax Income (+$)
Operating Income-1,167
Net Interest Income-84
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,396-939
EBIT - interestExpense = -1,251
-1,396
-1,389
Interest Expense84
Earnings Before Interest and Taxes (EBIT)-1,167-1,312
Earnings Before Interest and Taxes (EBITDA)-1,156
 
After tax Income (+$)
Income Before Tax-1,396
Tax Provision-0
Net Income From Continuing Ops-1,396-1,396
Net Income-1,473
Net Income Applicable To Common Shares-1,396
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,433
Total Other Income/Expenses Net-22884
 

Technical Analysis of Entia Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Entia Biosciences Inc. The general trend of Entia Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Entia Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Entia Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Entia Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Entia Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Entia Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Entia Biosciences Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Entia Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Entia Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Entia Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Entia Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartEntia Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Entia Biosciences Inc. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Entia Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Entia Biosciences Inc. The current sar is 0.0001003.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Entia Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Entia Biosciences Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Entia Biosciences Inc Daily Relative Strength Index (RSI) ChartEntia Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Entia Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Entia Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Entia Biosciences Inc Daily Stochastic Oscillator ChartEntia Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Entia Biosciences Inc. The current cci is -66.66666667.

Entia Biosciences Inc Daily Commodity Channel Index (CCI) ChartEntia Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Entia Biosciences Inc. The current cmo is 0.

Entia Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartEntia Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Entia Biosciences Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Entia Biosciences Inc Daily Williams %R ChartEntia Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Entia Biosciences Inc.

Entia Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Entia Biosciences Inc. The current atr is 0.

Entia Biosciences Inc Daily Average True Range (ATR) ChartEntia Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Entia Biosciences Inc. The current obv is -1,634,229.

Entia Biosciences Inc Daily On-Balance Volume (OBV) ChartEntia Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Entia Biosciences Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Entia Biosciences Inc Daily Money Flow Index (MFI) ChartEntia Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Entia Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Entia Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Entia Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Entia Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Entia Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Entia Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Entia Biosciences Inc

I send you an email if I find something interesting about Entia Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Entia Biosciences Inc.

Receive notifications about Entia Biosciences Inc in your mailbox!